NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE Drug Patent Profile
✉ Email this page to a colleague
When do Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate patents expire, and when can generic versions of Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate launch?
Norethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Amneal Pharms, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Apotex, Barr Labs Inc, Mylan Labs Ltd, and Xiromed. and is included in eleven NDAs.
The generic ingredient in NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 11 |
Finished Product Suppliers / Packagers: | 5 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE? | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE excipients list |
DailyMed Link: | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at DailyMed |